Alfredo Budillon

Trials

Studies that name Alfredo Budillon as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:57 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT05821556 · Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients

  National Cancer Institute, Naples · recruiting · Adenocarcinoma of the Pancreas · principal investigator
• N/A
  NCT05817227 · Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.

  National Cancer Institute, Naples · recruiting · Breast Cancer · principal investigator
• Ph2
  NCT04310176 · Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer

  National Cancer Institute, Naples · unknown · Ras-mutated Metastatic Colorectal Cancer · study chair
• Ph2
  NCT02624128 · Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck

  National Cancer Institute, Naples · unknown · Squamous Cell Carcinoma of the Head and Neck · principal investigator
• Ph2
  NCT02619435 · Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer

  National Cancer Institute, Naples · unknown · Advanced Colorectal Cancer · principal investigator
• Ph1
  NCT00415779 · ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer

  National Cancer Institute, Naples · completed · Metastatic Prostate Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.